Episode
HNSCC: Current and Emerging Therapeutic Strategies
- Published
- May 29, 2026
- Duration seconds
- 1584
- Processing state
not_requested
Actions
POST https://stenobird.com/v1/public/podcasts/decera-clinical-education-oncology-podcast-1302999/episodes/hnscc-current-and-emerging-therapeutic-strategies/transcription-requests
Idempotently request low-priority transcript generation for this episode.GET https://stenobird.com/podcast/decera-clinical-education-oncology-podcast-1302999/hnscc-current-and-emerging-therapeutic-strategies.md
Read the agent-friendly Markdown representation of this episode resource.
Summary
Join Aarti Bhatia, MD, MPH, and Deborah J. Wong, MD, PhD. for a discussion on the current and evolving treatment landscape in head and neck squamous cell carcinoma (HNSCC), including IO-based therapy, EGFR-targeted bispecific antibodies, antibody–drug conjugates, HPV-targeted vaccines, and novel radiosensitizers. Explore the latest phase III clinical trial data and emerging treatment sequencing strategies shaping the future of care for HPV-positive and HPV-negative patients with head and neck cancer. Listen now to stay ahead of the latest advances in HNSCC treatment.